MedPath

Evaluation of the berberis vulgaris effects against leishmaniasis

Phase 1
Recruiting
Conditions
Cutaneous leishmaniasis.
Cutaneous leishmaniasis
B55.1
Registration Number
IRCT20240510061730N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

positive leishmaniosis disease (except face)
not pregnant
ages: 20-70 y
not other diseases
normal kidney and liver tests

Exclusion Criteria

Facial lesions
pregnancy and lactation
Immunosuppressive medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.